Recent Advances in Serum Biomarkers for Cardiological Risk Stratification and Insight into the Cardiac Management of the Patients With Hematological Malignancies Treated With Targeted Therapy
Mihaela Andreescu · 2023
Read Recent Advances in Serum Biomarkers for Cardiological Risk Stratification and Insight into the Cardiac Management of the Patients With Hematological Malignancies Treated With Targeted Therapy by Mihaela Andreescu (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10688222.txt.
Description
Mihaela Andreescu wrote a 2023 review on blood markers that help doctors judge heart risk in blood cancer patients. Modern targeted drugs can harm the heart while they fight cancer. That damage raises the chance of illness and death for patients and survivors.
Blood markers offer a cheap way to spot risk early and sort patients by danger level. The review gathers recent studies on which markers help most in this group. It also covers how heart care should be planned for patients on targeted therapy. Much past work looked at standard chemo drugs, so this group needed its own summary. The goal is safer care that guards the heart during cancer treatment.
Catalog record
| CREATOR | Mihaela Andreescu |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |